Collagen Proportionate Area and Histological Grading of Fibrosis as Predictors of Clinical Outcomes and Mortality in Patients with Steatotic Liver Disease [0.03%]
脂肪肝病患者胶原比例面积和组织学分级对临床转归及死亡的预测价值
Andreas Bartholdy,Pernille Y Nielsen,Lise L Gluud et al.
Andreas Bartholdy et al.
Background/aims: Steatotic liver disease (SLD) including metabolic dysfunction-associated and alcoholic liver disease, is the most prevalent chronic liver condition globally. Liver biopsy remains the gold standard for fib...
Revolutionizing Liver Imaging: Artificial Intelligence-Driven Advances in Diagnostics and Staging [0.03%]
革新肝脏影像学：人工智能驱动的诊断和分期进展
Shritik Devkota,Harish Bhujade,Naveen Kalra
Shritik Devkota
Artificial intelligence (AI) has emerged as a transformative tool in liver imaging, offering enhanced diagnostic accuracy, efficiency, and reproducibility. The integration of machine learning and deep learning algorithms into radiological w...
When Epstein-Barr Virus Strikes Twice: Concurrent Lymphoproliferative and Smooth Muscle Tumor After Liver Transplantation! [0.03%]
移植后并发淋巴增生性和平滑肌肿瘤的EB病毒二次打击！
Dhiraj Agrawal,Shwetha Kamath,Sunil Gupta et al.
Dhiraj Agrawal et al.
Image 1. © 2025 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and dat...
Characterization of Both CD24+ and CD24- T Cells can Better Elucidate the Influence of CD24 on Cytokine Production [0.03%]
CD24+和CD24-T细胞的表征能更好地阐明CD24对细胞因子生成的影响
Zhencheng Zhang,Zaixing Yang
Zhencheng Zhang
Endoscopic Ultrasound-Directed Trans-Gastric ERCP for Management of Choledocholithiasis in a Roux-en-Y Gastric Bypass Anatomy [0.03%]
内镜超声引导下经胃ERCP治疗Roux-en-Y胃旁路术后胆总管结石患者
Sanish Ancil,Jahnvi Dhar,Rahul Thakur et al.
Sanish Ancil et al.
A Decade Long, Real-life Experience of Sofosbuvir-based Regimen Use for Hepatitis C Treatment in People With End-stage Renal Disease [0.03%]
索磷布韦为基础的治疗方案用于终末期肾病患者治疗丙型肝炎长达十年的真实世界经验
Ajay K Mishra,Dharmendra S Bhadauria,Surender Singh et al.
Ajay K Mishra et al.
Background/aims: Sofosbuvir (SOF) is a major directly acting antiviral (DAA) drug against hepatitis C virus (HCV) treatment. In patients with chronic kidney disease (CKD) and estimated glomerular filtration rate (eGFR)
Endoscopic Transpapillary Gallbladder Stenting for Complicated Cholecystitis in Patients With Cirrhosis and High Surgical Risk: An Observational Study [0.03%]
内镜经乳头胆囊造瘘术治疗肝硬化且手术风险高的复杂性胆囊炎患者：一项观察性研究
Arka De,Arpit Shastri,Sweta Rose et al.
Arka De et al.
Background: Patients with cholecystitis and underlying cirrhosis represent a high-risk group for surgical intervention. In patients otherwise meriting an endoscopic retrograde cholangiopancreatography (ERCP), endoscopic t...
Markedly Low Prevalence of Fatty Liver Despite Obesity in Prader-Willi Syndrome: A Search for Protective Genetic Markers [0.03%]
普拉德-威利综合征患者脂肪肝的低发病率及其保护性遗传标志物的研究
Omer Murik,Varda Gross-Tsur,Tzvia Mann et al.
Omer Murik et al.
Introduction and objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease across all age groups and is associated with significant morbidity and mortality. The pathogen...
Beyond Genetic Protection: Revisiting Hepatic Resilience in Prader-Willi Syndrome [0.03%]
超越遗传保护：重新审视普拉德-威利综合征肝弹性蛋白的功能
Nathkapach K Rattanapitoon,Chutharat Thanchonnang,Patpicha Arunsan et al.
Nathkapach K Rattanapitoon et al.
From Shunt to Strength: Toward an Indian Model of TIPS Prehabilitation [0.03%]
从分流到强化：印度型TIPS(经颈静脉肝内门体分流术)术前准备模式的转变
Vinay Jahagirdar,Ali Khan,Jasmohan S Bajaj
Vinay Jahagirdar